Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-23-025535
Filing Date
2023-07-25
Accepted
2023-07-25 09:08:28
Documents
15
Period of Report
2023-07-25

Document Format Files

Seq Description Document Type Size
1 6-K a230725_6kxmorxvotingright.htm 6-K 12823
2 EX-99.1 exhibit-991.htm EX-99.1 6878
3 EX-99.2 exhibit-992.htm EX-99.2 6877
4 GRAPHIC exhibit-991001.jpg GRAPHIC 131036
5 GRAPHIC exhibit-991002.jpg GRAPHIC 123207
6 GRAPHIC exhibit-991003.jpg GRAPHIC 125252
7 GRAPHIC exhibit-991004.jpg GRAPHIC 90335
8 GRAPHIC exhibit-991005.jpg GRAPHIC 96829
9 GRAPHIC exhibit-991006.jpg GRAPHIC 45027
10 GRAPHIC exhibit-992001.jpg GRAPHIC 131033
11 GRAPHIC exhibit-992002.jpg GRAPHIC 123310
12 GRAPHIC exhibit-992003.jpg GRAPHIC 125505
13 GRAPHIC exhibit-992004.jpg GRAPHIC 90335
14 GRAPHIC exhibit-992005.jpg GRAPHIC 96872
15 GRAPHIC exhibit-992006.jpg GRAPHIC 45027
  Complete submission text file 0001628280-23-025535.txt   1713991
Mailing Address SEMMELWEISSTR. 7 PLANEGG 2M 82152
Business Address SEMMELWEISSTR. 7 PLANEGG 2M 82152 49 89 89927-0
MorphoSys AG (Filer) CIK: 0001340243 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38455 | Film No.: 231106708
SIC: 2834 Pharmaceutical Preparations